SCIENSUS PHARMA SERVICES LIMITED
Every public sector contract SCIENSUS PHARMA SERVICES LIMITED has won, with the buyer, value and end date for each. When these contracts approach their end date they usually return to the market. Business predicts when, follows SCIENSUS PHARMA SERVICES LIMITED for you, and alerts you the moment a renewal goes live.
Where they win
The sectors, tender types and buyers where SCIENSUS PHARMA SERVICES LIMITED wins most often.
See every live NHS tenders and find your next contract before they do.
Similar suppliers
See all NHS buyers and UK contract awards.
Sectors
Top Buyers
Awards(36)
AGALSIDASE ALFA 3.5MG/3.5ML CONCENTRATE FOR SOLUTION FOR INFUSION, 3.5 mL, vial, PACK OF 1 (HOMECARE)
Nemolizumab 30MG PEN (HOMECARE)
SECUKINUMAB (COSENTYX) 150 mg and 300mg Pre-filled Pen and Syringes via homecare
Etanercept (Enbrel) Homecare 50mg
FILGOTINIB (JYSELECA) Tablets [HOMECARE]
PEGUNIGALSIDASE ALFA SOLUTION FOR INFUSION VIAL
ALTUVOCT POWDER and SOLVENT FOR SOLUTION FOR INJECTION VIAL
IDURSULFASE 6MG/3ML CONCENTRATE FOR SOLUTION FOR INFUSION
PANZYGA SOLUTION FOR INFUSION
BARICITINIB TABLETS
SECUKINUMAB (COSENTYX) HOMECARE MAINTENANCE 2 WEEKLY 300 mg Pre-Filled Pen 1 Pen Pack
CERTOLIZUMAB PEGOL PRE-FILLED PENS and SYRINGES 200MG/1ML INJECTION (homecare)
SECUKINUMAB PEN (COSENTYX) HOMECARE 300 mg Pre-filled Injection
IXEKIZUMAB 80mg PRE-FILLED PENS and SYRINGES (Homecare)
D102 - Framework Agreement for the Provision of a Mid- Tech Homecare Service for the Dispensing and Home Delivery of Self-Injecting and Self-Infused Products (including Pharma Funded Schemes) and removal of waste
RISANKIZUMAB 360MG SOLUTION FOR INJECTION HOMECARE
Framework for the Provision of Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Including Immunotherapies
Framework for the provision of a Low-Tech Dispense and Delivery Service
Contract for Purchase of Secukinumab (Homecare)
Supply of an Injectable Chemotherapy (and other high tech medicines) Homecare Service
Why track SCIENSUS PHARMA SERVICES LIMITED?
SCIENSUS PHARMA SERVICES LIMITED is an active supplier to UK public sector buyers. Their contract history is one of the clearest guides to where the work is: which authorities they serve, what those contracts are worth, and, most usefully, when each contract is due to end. A contract nearing its end date is an opportunity, because the buyer will usually run the work again.
How renewal tracking works
We aggregate SCIENSUS PHARMA SERVICES LIMITED's award notices from 600+ UK and Irish sources and read the end date on each contract. From those dates, Business predicts when each contract is likely to be re-tendered and, if you follow the supplier, alerts you the moment a matching tender goes live. That head start lets you speak to the buyer and prepare a bid before the incumbent is confirmed again.
What you can do here
- Review the full history. Every contract SCIENSUS PHARMA SERVICES LIMITED has won, with the buyer, value and dates for each.
- Spot upcoming renewals. Contracts approaching their end date are the ones most likely to reopen.
- Track and get alerted. Follow SCIENSUS PHARMA SERVICES LIMITED and be notified when their contracts come up again (Business).
- Benchmark and target. See which buyers rely on them and at what value, then focus where you can win.
Frequently asked questions
Where does this data come from?
Official UK and Irish contract award notices, aggregated from 600+ sources and updated daily.
Is the contract history free?
Yes. The full award history, values and buyers are free to browse. Predicted renewal dates, following a supplier and renewal alerts are part of our Business plans.
How do you predict renewals?
From the end dates and durations recorded on awarded contracts. A contract at or near its end date is a strong candidate to return to the market.